ClinicalTrials.Veeva

Menu

iotaSOFT Pediatric Study

I

iotaMotion

Status

Completed

Conditions

Hearing Loss, Bilateral
Hearing Loss, Unilateral
Hearing Loss, Sensorineural

Treatments

Device: iotaSOFT Insertion System

Study type

Interventional

Funder types

Industry

Identifiers

NCT06106373
iotaSOFT000002

Details and patient eligibility

About

Prospective, non-randomized, open-label study to evaluate the safety and efficacy of the iotaSOFT Insertion System when used to assist electrode array insertion during cochlear implant surgery in a pediatric population.

Enrollment

20 patients

Sex

All

Ages

9 months to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Candidate for unilateral or bilateral cochlear implantation according to indications for use with FDA approved cochlear implant devices
  • Age 9 months to less than 12 years old at the time of CI surgery
  • Willingness to participate in the study and able to comply with the follow-up visit requirements

Exclusion criteria

  • Prior cochlear implantation in the ear to be implanted
  • Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array or present an increased risk of aberrant insertion
  • Craniofacial abnormality, temporal squamosal skull thickness less than 3mm, major cochlear lesions, or cochlear malformations
  • Deafness due to lesions of the acoustic nerve or central auditory pathway
  • Diagnosis of auditory neuropathy.
  • Active middle-ear infection or tympanic membrane perforation in the presence of active middle-ear disease
  • Absence of cochlear development
  • Additional medical concerns that would prevent participation in evaluations as determined by the investigator
  • Planned or current participation in a clinical study of an investigational device or drug

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Pediatric Cochlear Implant Recipient
Experimental group
Description:
Pediatric subjects receiving a cochlear implant between the ages of 9 months and under 12 years of age.
Treatment:
Device: iotaSOFT Insertion System

Trial contacts and locations

2

Loading...

Central trial contact

Laura Chenier, AuD; Wade Colburn

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems